Computer Algorithm-Based Hydroxyurea Dosing Facilitates Titration to Maximum Tolerated Dose in Sickle Cell Anemia.

Journal of Clinical Pharmacology
Mahogany OldhamCourtney D Fitzhugh

Abstract

Adults with sickle cell disease (SCD) experience acute and chronic complications and die prematurely. When taken at maximum tolerated dose (MTD), hydroxyurea prolongs survival; however, it has not consistently reversed organ dysfunction. Patients also frequently do not take hydroxyurea, at least in part because of physician discomfort with prescribing hydroxyurea. We sought to develop a computer program that could easily titrate hydroxyurea to MTD. This was a single-arm, open-label pilot study. Fifteen patients with homozygous SCD were enrolled in the protocol, and 10 patients were followed at baseline and then for 1 year after hydroxyurea initiation or dose titration. Fetal hemoglobin significantly increased in all 10 patients from 8.3% to 25.1% (P < .001). Nine patients were titrated to MTD in an average of 7.9 months, and the tenth patient's hydroxyurea dose was increased to 33 mg/kg/day. Computer program dosing recommendations were the same as manual dosing decisions made using the same algorithm for all patients and at all times. We also evaluated markers of cardiopulmonary, liver and renal damage. Although cardiopulmonary function did not significantly improve, direct bilirubin and alanine aminotransferase levels signific...Continue Reading

References

Apr 12, 1990·The New England Journal of Medicine·G P RodgersA W Nienhuis
Oct 15, 1991·Annals of Internal Medicine·D R PowarsC Johnson
Aug 1, 1984·The Journal of Clinical Investigation·O S PlattD G Nathan
Aug 28, 1982·British Medical Journal·A N ThomasG R Serjeant
Jun 9, 1994·The New England Journal of Medicine·O S PlattP P Klug
Apr 18, 2002·The Hematology Journal : the Official Journal of the European Haematology Association·Véronique PerronneBertrand Godeau
Feb 27, 2004·The New England Journal of Medicine·Mark T GladwinFrederick P Ognibene
Sep 30, 2004·Blood·Sule M BakanayAbdullah Kutlar
Feb 11, 2005·Pediatric Blood & Cancer·Courtney D FitzhughRussell E Ware
Aug 23, 2006·American Journal of Hematology·Deepika S DarbariOswaldo Castro
Sep 1, 2006·Health and Quality of Life Outcomes·Samir K BallasDuane R Bonds
May 26, 2007·The American Journal of Forensic Medicine and Pathology·Jason K GrahamMario Mosunjac
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Dec 24, 2009·American Journal of Hematology·Courtney D FitzhughLaura M De Castro
Apr 2, 2010·American Journal of Preventive Medicine·Kathryn L Hassell
Apr 9, 2010·Journal of the American Geriatrics Society·Isabelle Gouin-ThibaultVirginie Siguret
Jun 1, 2010·American Journal of Hematology·Martin H SteinbergUNKNOWN Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up
Jun 12, 2010·BMC Geriatrics·Alexandra PapaioannouUNKNOWN Improving Prescribing in Long Term Care Investigators
Apr 26, 2011·Journal of Pediatric Hematology/oncology·Courtney D ThornburgJulie A Panepinto
Mar 2, 2013·Public Health Reports·Sophie LanzkronCarlton Haywood
Apr 18, 2013·British Journal of Haematology·Clarisse Lopes de Castro LoboJane S Hankins
Jul 9, 2013·British Journal of Haematology·Payal C DesaiKenneth I Ataga
Oct 3, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Louis-Philippe LaurinVimal K Derebail
Jun 18, 2014·International Journal of Clinical Pharmacy·Geraldo B Silva JuniorElizabeth F Daher
Aug 15, 2014·International Journal of Health Care Quality Assurance·Emmanuel NwenyiNkonye Ezeobah
Jul 1, 2015·Annals of Hematology·Maria Carmen M VasconcelosTeresa Cristina A Ferrari
Aug 4, 2015·Alimentary Pharmacology & Therapeutics·J J FeldT Heller
Nov 21, 2015·Journal of the American Society of Nephrology : JASN·Pablo BartolucciVincent Audard
Aug 30, 2016·American Journal of Hematology·Thomas StehléVincent Audard
Nov 15, 2016·Cardiology in the Young·Philippe M AdjagbaNagib Dahdah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

BETA Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation
M Bowers
BETA Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation
C Gortner
Archives of Dermatology
L D Roe, J W Wilson
Positively Aware : the Monthly Journal of the Test Positive Aware Network
© 2021 Meta ULC. All rights reserved